Abstract
Chromoblastomycosis is a chronic cutaneous and subcutaneous mycosis. The management of this infection continues to be challenging because there is no consensus on the therapeutic regimen. We report here a case of a 69-year-old male patient with cauliflower-like lesions on his left leg and foot. He had already been treated with itraconazole at a dose of 200 mg/day for 5 months, with mycological cure for all the affected areas. However, the lesions relapsed at both sites, and treatment with itraconazole was resumed at the dose previously used. Initially, direct mycological examination, cultural, and microculture slide observation were performed. Afterward, sequencing of the ITS1-5.8S rDNA-ITS2 region of the fungal DNA and evaluation of its susceptibility to antifungal agents alone and in combination were performed. In direct mycological examination, the presence of sclerotic cells was verified, and the fungus was identified as Fonsecaea based on cultural and microscopic examinations. Identification as Fonsecaea monophora was confirmed after sequencing of the ITS region and phylogenetic analysis. The isolate was susceptible to itraconazole and terbinafine. The combinations of amphotericin B and terbinafine and terbinafine and voriconazole were synergistic. The use of drugs for which the causative agent is susceptible to singly or in combination may be an alternative for the treatment of mycosis. Furthermore, the identification of the agent by molecular techniques is important for epidemiological purposes. To the best of our knowledge, this is the first case of relapsed chromoblastomycosis caused by F. monophora in Brazil.
References
Queiroz-Telles F, Esterre P, Perez-Blanco M, et al. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med Mycol. 2009;47(1):3–15.
Ameen M. Managing chromoblastomycosis. Trop Doct. 2010;40:65–7.
Torres-Guerrero E, Isa–Isa R, Isa M, et al. Chromoblastomycosis. Clin Dermatol. 2012;30:403–8.
Alviano DS, Kneipp LF, Lopes AH, et al. Differentiation of Fonsecaea pedrosoi mycelial forms into sclerotic cells is induced by platelet-activating factor. Res Microbiol. 2003;154:689–95.
De Hoog GS, Attili-Angelis D, Vicente VA, et al. Molecular ecology and pathogenic potencial of Fonsecaea species. Med Mycol. 2004;42:405–16.
Najafzadeh MJ, Gueidan C, Badali H, et al. Genetic diversity and species delimitation in the opportunistic genus Fonsecaea. Med Mycol. 2009;47:17–25.
Najafzadeh MJ, Vicente VA, Sun J, et al. Fonsecaea multimorphosa sp. nov, a new opportunistic species of Chaetothyriales isolated from a feline cerebral abscess. Fungal Biol. 2011;115:1066–76.
Surash S, Tyagi A, de Hoog GS, et al. Cerebral phaeohyphomycosis caused by Fonsecaea monophora. Med Mycol. 2005;43:465–72.
Zhang J, Xi L, Lu C, et al. Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China. Mycoses. 2009;52:176–81.
Bonifaz A, Paredes-Solis V, Saul A. Treating chromoblastomycosis with systemic antifungals. Expert Opin Pharmacother. 2004;5:247–54.
Criado PR, Careta MF, Valente NY, et al. Extensive long-standing chromomycosis due to Fonsecaea pedrosoi: three cases with relevant improvement under voriconazole therapy. J Dermatol Treat. 2011;22:167–74.
Yang Y, Hu Y, Zhang J, et al. A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy. Med Mycol. 2012;50:649–53.
Najafzadeh MJ, Rezusta A, Cameo MI, et al. Successful treatment of chomoblastomycosis of 36 years duration caused by Fonsecaea monophora. Med Mycol. 2010;48(2):390–3.
Valente P, Boekhout T, Landell MF, et al. Bandoniozyma gen. nov. a genus of fermentative and non-fermentative Tremellaceous yeast species. PLoS ONE. 2012;7(10):e46060.
Tamura K, Peterson D, Peterson N, et al. MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28:2731–9.
Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. 2nd edn. Wayne, PA: Clinical and Laboratory Standards Institute (CLSI), 2008—Approved Standard M38-A2.
Cuenca-Estrella M. Combinations of antifungal agents in therapy–what value are they? Antimicrob Agents Chemother. 2004;54:854–69.
Gómez-López A, Cuenca-Estrella M, Mellado E, et al. In vitro evaluation of combination of terbinafine with itraconazole or amphotericin B against Zygomycota. Diagn Microbiol Infect Dis. 2003;45:199–202.
Argenta JS, Santurio JM, Alves SH, et al. In vitro activities of voriconazole, itraconazole and terbinafine alone or in combination against Pythium insidiosum isolates from Brazil. Antimicrob Agents Chemother. 2008;52:767–9.
Daboit TC, Duquia RP, Magagnin CM, et al. A case of Exophiala spinifera infection in Southern Brazil: molecular identification and antifungal susceptibility. Med. Mycol. Case Rep. 2012;1:72–5.
Lim SW, Suh MK, Kang GS, et al. Molecular phylogenetics of Fonsecaea strains isolated from chromoblastomycosis patients in South Korea. Mycoses. 2010;54:415–20.
Najafzadeh MJ, Sun J, Vicente V, et al. Fonsecaea nubica sp. nov, a new agent of human chromoblastomycosis revealed using molecular data. Med Mycol. 2010;48(6):800–6.
Vicente VA, Orélis-Ribeiro R, Najafzadeh MJ, Sun J, Guerra RS, Miesch S, Ostrensky A, Meis JF, Klaassen CH, de Hoog GS, Boeger WA. Black yeast-like fungi associated with lethargic crab disease (LCD) in the mangrove-land crab, Ucides cordatus (Ocypodidae). Vet Microbiol. 2012;158:109–22.
Bonifaz A, Carrasco-Gerard E, Saul A. Chromoblastomycosis: clinical and mycologic experience of 51 cases. Mycoses. 2001;44:1–7.
de Cardoso Brito A. Chromoblastomycosis. In: Tyring S, Lupi O, Hengge U, editors. Tropical dermatology. New York: Churchill Livingstone; 2006. p. 203–5.
Hamza SH, Mercado PJ, Skelton HG, et al. An unusual dematiaceous fungal infection of the skin caused by Fonsecaea pedrosoi: a case report and review of the literature. J Cutan Pathol. 2003;30:340–3.
Martínez RL, Tovar LJM. Chromoblastomycosis. Clin Dermatol. 2007;25:188–94.
Salgado CG, Silva MB, Yamano SSP, et al. Cutaneous localized annular chromoblastomycosis. J Cutan Pathol. 2009;36:257–61.
Wu P, Turner ML, Cowen EW, et al. Sixty-year-old man with slowly expanding nodular plaque on the thigh. J Am Acad Dermatol. 2010;63(6):1083–7.
Naveen KN, Shetty PC, Naik AS, et al. Chromoblastomycosis presenting as a phagedenic ulcer on the face. Int J Dermatol. 2012;51:576–8.
França K, Villa RT, Bastos VRA, et al. Auricular chromoblastomycosis: a case report and review of published literature. Mycopathologia. 2011;172:69–72.
Zhang J, Xi L, Zhang H. Synergistic effects of terbinafine and itraconazole on clinical isolates of Fonsecaea monophora. Eur J Dermatol. 2009;19(5):451–5.
Yu J, Ruoyu L, Zhang M, et al. In vitro interactions of terbinafine with itraconazole and amphotericin B against fungi causing chromoblastomycosis in China. Med Mycol. 2008;46:745–7.
Najafzadeh MJ, Badali H, Illnait-Zaragozi MT. In Vitro Activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp. Antimicrob Agents Chemother. 2010;54(4):1636–8.
Bae SK, Park SJ, Shim EJ, et al. Increased oral bioavailability of itraconazole and its active metabolite, 7-hydroxyitraconazole, when coadministered with a vitamin C beverage in healthy participants. J Clin Pharmacol. 2011;51:444–51.
Hof H. Mycoses in the elderly. Eur J Clin Microbiol Infect Dis. 2010;29:5–13.
Saeed S, Sagatys E, Wasserman JR, et al. Geriatric Fungal Infections. In: Norman RA, editor. Diagnosis of Aging Skin Diseases. London: Springer-Verlag; 2008. p. 123–50.
Acknowledgments
The authors thank the CAPES (Coordenação de aperfeiçoamento de Pessoal de Nível Superior) and the CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico) for the financial support and scholarships. CNPq Process n º 482635/2010-0.
Conflict of interest
The authors declare there are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Daboit, T.C., Magagnin, C.M., Heidrich, D. et al. A Case of Relapsed Chromoblastomycosis Due to Fonsecaea monophora: Antifungal Susceptibility and Phylogenetic Analysis. Mycopathologia 176, 139–144 (2013). https://doi.org/10.1007/s11046-013-9660-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-013-9660-1